These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7527152)

  • 1. Differential effects of benzodiazepines, including diazepam, clonazepam, Ro 5-4864 and devazepide, on lindane-induced toxicity.
    Woolley DE
    Proc West Pharmacol Soc; 1994; 37():131-4. PubMed ID: 7527152
    [No Abstract]   [Full Text] [Related]  

  • 2. "Central" and "peripheral" benzodiazepines and kinetics of lindane-induced toxicity.
    Griffith JA; Woolley DE
    Pharmacol Biochem Behav; 1989 Feb; 32(2):367-76. PubMed ID: 2471214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of hypothermic effect of cholecystokinin by benzodiazepines and a benzodiazepine antagonist, Ro 15-1788, in mice.
    Sugaya K; Matsuda I; Kubota K
    Jpn J Pharmacol; 1985 Oct; 39(2):277-80. PubMed ID: 2868143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that decreased feeding induced by systemic injection of cholecystokinin is mediated by CCK-A receptors.
    Dourish CT; Ruckert AC; Tattersall FD; Iversen SD
    Eur J Pharmacol; 1989 Dec; 173(2-3):233-4. PubMed ID: 2625140
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of the CCKA antagonist devazepide on eating stimulated by raphe injection of 8-OH-DPAT.
    Currie PJ; Coscina DV
    Neuroreport; 1995 Dec; 7(1):253-6. PubMed ID: 8742464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of antinociceptive effect of cholecystokinin by benzodiazepines and a benzodiazepine antagonist, Ro 15-1788.
    Kubota K; Sugaya K; Matsuda I; Matsuoka Y; Terawaki Y
    Jpn J Pharmacol; 1985 Jan; 37(1):101-5. PubMed ID: 2859382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cholecystokinin antagonists: anxiolytic drugs of the future].
    Bourin M; Bradwejn J
    Pathol Biol (Paris); 1992 Mar; 40(3):215-7. PubMed ID: 1608663
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible involvement of the CCK receptor in the benzodiazepine antagonism to CCK in the mouse brain.
    Sugaya K; Matsuda I; Kubota K
    Jpn J Pharmacol; 1987 Jan; 43(1):67-71. PubMed ID: 2883334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area.
    Meltzer LT; Christoffersen CL; Serpa KA; Razmpour A
    Synapse; 1993 Feb; 13(2):117-22. PubMed ID: 8446920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist.
    Wolkowitz OM; Gertz B; Weingartner H; Beccaria L; Thompson K; Liddle RA
    Biol Psychiatry; 1990 Jul; 28(2):169-73. PubMed ID: 2378921
    [No Abstract]   [Full Text] [Related]  

  • 11. Caerulein and cholecystokinin octapeptide (CCK-8): sedative and anticonvulsive effects in mice unaffected by the benzodiazepine antagonist Ro 15-1788.
    Zetler G
    Neurosci Lett; 1982 Mar; 28(3):287-90. PubMed ID: 6281694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus.
    Farook JM; Zhu YZ; Wang Q; Moochhala SM; Lee L; Wong PT
    Neurosci Lett; 2004 Apr; 358(3):215-9. PubMed ID: 15039119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of cholecystokinin receptor antagonists in CNS disorders.
    Schiantarelli P
    Pharmacol Res; 1993; 28(1):1-9. PubMed ID: 8234141
    [No Abstract]   [Full Text] [Related]  

  • 14. [Differentiation by animals of visual signals as affected by benzodiazepine tranquilizers].
    Machula AI; Barkov NK; Fisenko VP
    Farmakol Toksikol; 1982; 45(2):13-5. PubMed ID: 6122594
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of opioid antagonists on anticonvulsant and hypnotic activity of benzodiazepines.
    Fidecka S; Langwiński R
    Pol J Pharmacol; 1996; 48(4):409-14. PubMed ID: 9112681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicokinetics of Ro 5-4864, lindane and picrotoxin compared.
    Drummer HL; Woolley DE
    Pharmacol Biochem Behav; 1991 Feb; 38(2):235-42. PubMed ID: 1711699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of MK-329 on gastric emptying of solids in cats.
    Hornof WJ; Koblik PD
    J Nucl Med; 1991 Mar; 32(3):547-8. PubMed ID: 2005467
    [No Abstract]   [Full Text] [Related]  

  • 18. Ionic mechanisms underlying cholecystokinin action in rat brain.
    Boden P; Woodruff GN
    Ann N Y Acad Sci; 1994 Mar; 713():129-37. PubMed ID: 7910440
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of benzodiazepines on neuropathologic syndromes of spinal origin].
    Kryshanovskiĭ GN; Grafova VN; Danilova EI
    Biull Eksp Biol Med; 1984 Jan; 97(1):25-7. PubMed ID: 6692021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MK-329 has no direct effect on the pancreas.
    Berlin RG
    Gastroenterology; 1989 Aug; 97(2):553-4. PubMed ID: 2744367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.